IKBKB and age-related macular degeneration: The former strategy has been demonstrated in pre-clinical studies investigating the use of IKKβ inhibitors to treat choroid neovascularization (CNV), which is a major pathological change associated with exudative age-related macular degeneration (AMD) [223].